Skip to main content
Erschienen in: International Urogynecology Journal 2/2010

01.02.2010 | Original Article

A validated self-administered female pelvic floor questionnaire

verfasst von: Kaven Baessler, Sheila M. O’Neill, Christopher F. Maher, Diana Battistutta

Erschienen in: International Urogynecology Journal | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The aim of this study was to validate a self-administered version of the already validated interviewer-administered Australian pelvic floor questionnaire.

Methods

The questionnaire was completed by 163 women attending an urogynecological clinic. Face and convergent validity was assessed. Reliability testing and comparison with the interviewer-administered version was performed in a subset of 105 patients. Responsiveness was evaluated in a subset of 73 women.

Results

Missing data did not exceed 4% for any question. Cronbach’s alpha coefficients were acceptable in all domains. Kappa coefficients for the test–retest analyses varied from 0.64–1.0. Prolapse symptoms correlated significantly with the pelvic organ prolapse quantification. Urodynamics confirmed the reported symptom stress incontinence in 70%. The self and interviewer-administered questionnaires demonstrated equivalence. Effect sizes ranged from 0.6 to 1.4.

Conclusions

This self-administered pelvic floor questionnaire assessed pelvic floor function in a reproducible and valid fashion and due to its responsiveness, can be used for routine clinical assessment and outcome research.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Baessler K, O'Neill SM, Maher CF, Battistutta D (2009) Australian pelvic floor questionnaire: a validated interviewer-administered pelvic floor questionnaire for routine clinic and research. Int Urogynecol J Pelvic Floor Dysfunct 20:149–158CrossRefPubMed Baessler K, O'Neill SM, Maher CF, Battistutta D (2009) Australian pelvic floor questionnaire: a validated interviewer-administered pelvic floor questionnaire for routine clinic and research. Int Urogynecol J Pelvic Floor Dysfunct 20:149–158CrossRefPubMed
2.
Zurück zum Zitat Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JOL, Klarskov P et al (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am j Obstet Gynecol 175:10–17CrossRefPubMed Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JOL, Klarskov P et al (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am j Obstet Gynecol 175:10–17CrossRefPubMed
3.
Zurück zum Zitat Koch GG, Landis JR, Freeman JL, Freeman DH Jr, Lehnen RC (1977) A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics 33:133–158CrossRefPubMed Koch GG, Landis JR, Freeman JL, Freeman DH Jr, Lehnen RC (1977) A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics 33:133–158CrossRefPubMed
4.
Zurück zum Zitat Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310PubMed Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310PubMed
5.
Zurück zum Zitat Gill TM, Feinstein AR (1994) A critical appraisal of the quality of quality-of-life measurements. JAMA 272:619–626CrossRefPubMed Gill TM, Feinstein AR (1994) A critical appraisal of the quality of quality-of-life measurements. JAMA 272:619–626CrossRefPubMed
6.
Zurück zum Zitat Kazis LE, Anderson JJ, Meenan RF (1989) Effect sizes for interpreting changes in health status. Med Care 27:S178–S189CrossRefPubMed Kazis LE, Anderson JJ, Meenan RF (1989) Effect sizes for interpreting changes in health status. Med Care 27:S178–S189CrossRefPubMed
7.
Zurück zum Zitat Katz JN, Harris TM, Larson MG, Krushell RJ, Brown CH, Fossel AH et al (1992) Predictors of functional outcomes after arthroscopic partial meniscectomy. J Rheumatol 19:1938–1942PubMed Katz JN, Harris TM, Larson MG, Krushell RJ, Brown CH, Fossel AH et al (1992) Predictors of functional outcomes after arthroscopic partial meniscectomy. J Rheumatol 19:1938–1942PubMed
8.
Zurück zum Zitat Amarenco G, Arnould B, Carita P, Haab F, Labat JJ, Richard F (2003) European psychometric validation of the CONTILIFE: a quality of life questionnaire for urinary incontinence. Eur Urol 43:391–404CrossRefPubMed Amarenco G, Arnould B, Carita P, Haab F, Labat JJ, Richard F (2003) European psychometric validation of the CONTILIFE: a quality of life questionnaire for urinary incontinence. Eur Urol 43:391–404CrossRefPubMed
9.
Zurück zum Zitat Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA (1994) Health-related quality of life measures for women with urinary incontinence: the incontinence impact questionnaire and the urogenital distress inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 3:291–306CrossRefPubMed Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA (1994) Health-related quality of life measures for women with urinary incontinence: the incontinence impact questionnaire and the urogenital distress inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 3:291–306CrossRefPubMed
10.
Zurück zum Zitat Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374–1379PubMed Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374–1379PubMed
11.
Zurück zum Zitat Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P (1996) The Bristol female lower urinary tract symptoms questionnaire: development and psychometric testing. Br J Urol 77:805–812PubMed Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P (1996) The Bristol female lower urinary tract symptoms questionnaire: development and psychometric testing. Br J Urol 77:805–812PubMed
12.
Zurück zum Zitat Kulseng-Hanssen S, Borstad E (2003) The development of a questionnaire to measure the severity of symptoms and the quality of life before and after surgery for stress incontinence. Bjog 110:983–988PubMed Kulseng-Hanssen S, Borstad E (2003) The development of a questionnaire to measure the severity of symptoms and the quality of life before and after surgery for stress incontinence. Bjog 110:983–988PubMed
13.
Zurück zum Zitat Bug GJ, Kiff ES, Hosker G (2001) A new condition-specific health-related quality of life questionnaire for the assessment of women with anal incontinence. Bjog 108:1057–1067CrossRefPubMed Bug GJ, Kiff ES, Hosker G (2001) A new condition-specific health-related quality of life questionnaire for the assessment of women with anal incontinence. Bjog 108:1057–1067CrossRefPubMed
14.
Zurück zum Zitat Reilly WT, Talley NJ, Pemberton JH, Zinsmeister AR (2000) Validation of a questionnaire to assess fecal incontinence and associated risk factors: fecal incontinence questionnaire. Dis Colon Rectum 43:146–153 discussion 153-4CrossRefPubMed Reilly WT, Talley NJ, Pemberton JH, Zinsmeister AR (2000) Validation of a questionnaire to assess fecal incontinence and associated risk factors: fecal incontinence questionnaire. Dis Colon Rectum 43:146–153 discussion 153-4CrossRefPubMed
15.
Zurück zum Zitat Barber MD, Kuchibhatla MN, Pieper CF, Bump RC (2001) Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 185:1388–1395CrossRefPubMed Barber MD, Kuchibhatla MN, Pieper CF, Bump RC (2001) Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 185:1388–1395CrossRefPubMed
16.
Zurück zum Zitat Lukacz ES, Lawrence JM, Buckwalter JG, Burchette RJ, Nager CW, Luber KM (2005) Epidemiology of prolapse and incontinence questionnaire: validation of a new epidemiologic survey. Int Urogynecol J Pelvic Floor Dysfunct 16:272–284CrossRefPubMed Lukacz ES, Lawrence JM, Buckwalter JG, Burchette RJ, Nager CW, Luber KM (2005) Epidemiology of prolapse and incontinence questionnaire: validation of a new epidemiologic survey. Int Urogynecol J Pelvic Floor Dysfunct 16:272–284CrossRefPubMed
17.
Zurück zum Zitat Abrams P, Avery K, Gardener N, Donovan J (2006) The international consultation on incontinence modular questionnaire: www.iciq.net. J Urol 175:1063–1066; discussion 1066 Abrams P, Avery K, Gardener N, Donovan J (2006) The international consultation on incontinence modular questionnaire: www.​iciq.​net. J Urol 175:1063–1066; discussion 1066
18.
Zurück zum Zitat Avery KN, Bosch JL, Gotoh M, Naughton M, Jackson S, Radley SC et al (2007) Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol 177:39–49CrossRefPubMed Avery KN, Bosch JL, Gotoh M, Naughton M, Jackson S, Radley SC et al (2007) Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol 177:39–49CrossRefPubMed
19.
Zurück zum Zitat Barber MD, Walters MD, Bump RC (2005) Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 193:103–113CrossRefPubMed Barber MD, Walters MD, Bump RC (2005) Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 193:103–113CrossRefPubMed
20.
Zurück zum Zitat Price N, Jackson SR, Avery K, Brookes ST, Abrams P (2006) Development and psychometric evaluation of the ICIQ vaginal symptoms questionnaire: the ICIQ-VS. Bjog 113:700–712PubMed Price N, Jackson SR, Avery K, Brookes ST, Abrams P (2006) Development and psychometric evaluation of the ICIQ vaginal symptoms questionnaire: the ICIQ-VS. Bjog 113:700–712PubMed
21.
Zurück zum Zitat Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P (2004) ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 23:322–330CrossRefPubMed Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P (2004) ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 23:322–330CrossRefPubMed
22.
Zurück zum Zitat Cotterill N, Norton C, Avery KN, Abrams P, Donovan JL (2008) A patient-centered approach to developing a comprehensive symptom and quality of life assessment of anal incontinence. Dis Colon Rectum 51:82–87CrossRefPubMed Cotterill N, Norton C, Avery KN, Abrams P, Donovan JL (2008) A patient-centered approach to developing a comprehensive symptom and quality of life assessment of anal incontinence. Dis Colon Rectum 51:82–87CrossRefPubMed
23.
Zurück zum Zitat Kirshner B, Guyatt G (1985) A methodological framework for assessing health indices. J Chronic Dis 38:27–36CrossRefPubMed Kirshner B, Guyatt G (1985) A methodological framework for assessing health indices. J Chronic Dis 38:27–36CrossRefPubMed
24.
Zurück zum Zitat Guyatt G, Walter S, Norman G (1987) Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 40:171–178CrossRefPubMed Guyatt G, Walter S, Norman G (1987) Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 40:171–178CrossRefPubMed
25.
Zurück zum Zitat Norman GR, Sridhar FG, Guyatt GH, Walter SD (2001) Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care 39:1039–1047CrossRefPubMed Norman GR, Sridhar FG, Guyatt GH, Walter SD (2001) Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care 39:1039–1047CrossRefPubMed
26.
Zurück zum Zitat Lydick E, Epstein RS (1993) Interpretation of quality of life changes. Qual Life Res 2:221–226CrossRefPubMed Lydick E, Epstein RS (1993) Interpretation of quality of life changes. Qual Life Res 2:221–226CrossRefPubMed
27.
Zurück zum Zitat Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T (2005) Estimating clinically significant differences in quality of life outcomes. Qual Life Res 14:285–295CrossRefPubMed Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T (2005) Estimating clinically significant differences in quality of life outcomes. Qual Life Res 14:285–295CrossRefPubMed
28.
Zurück zum Zitat Norman GR, Wyrwich KW, Patrick DL (2007) The mathematical relationship among different forms of responsiveness coefficients. Qual Life Res 16:815–822CrossRefPubMed Norman GR, Wyrwich KW, Patrick DL (2007) The mathematical relationship among different forms of responsiveness coefficients. Qual Life Res 16:815–822CrossRefPubMed
29.
Zurück zum Zitat Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41:582–892CrossRefPubMed Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41:582–892CrossRefPubMed
Metadaten
Titel
A validated self-administered female pelvic floor questionnaire
verfasst von
Kaven Baessler
Sheila M. O’Neill
Christopher F. Maher
Diana Battistutta
Publikationsdatum
01.02.2010
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 2/2010
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-009-0997-4

Weitere Artikel der Ausgabe 2/2010

International Urogynecology Journal 2/2010 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.